| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9343(02)01103-8 |
| P698 | PubMed publication ID | 12034408 |
| P50 | author | Richard W. Grant | Q44847756 |
| James B. Meigs | Q64426927 | ||
| P2093 | author name string | Daniel E Singer | |
| David M Nathan | |||
| Enrico Cagliero | |||
| Patricia Murphy-Sheehy | |||
| P2860 | cites work | Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions | Q69123357 |
| Retinopathy in older type II diabetics. Association with glucose control | Q69546297 | ||
| Detection and management of lipid disorders in diabetes. American Diabetes Association | Q70721275 | ||
| Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group | Q71181134 | ||
| NIDDM and its metabolic control predict coronary heart disease in elderly subjects | Q72080013 | ||
| Standards of medical care for patients with diabetes mellitus. American Diabetes Association | Q72179968 | ||
| The association of glycemia and cause-specific mortality in a diabetic population | Q72855277 | ||
| Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians | Q73098412 | ||
| Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) | Q73209707 | ||
| Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes | Q73249273 | ||
| Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) | Q78252124 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993 | Q28275663 | ||
| Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study | Q29617822 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| Final report on the aspirin component of the ongoing Physicians' Health Study | Q29619461 | ||
| Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
| Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies | Q31032719 | ||
| Hyperglycemia and cardiovascular disease in type 2 diabetes | Q33637016 | ||
| Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude | Q33954035 | ||
| Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes | Q34745500 | ||
| Does hyperglycemia really cause coronary heart disease? | Q41603998 | ||
| Evaluating hypertension control in a managed care setting | Q41707752 | ||
| A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors | Q43506884 | ||
| Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. | Q44530036 | ||
| Change and correlates of change in high and low density lipoprotein cholesterol after six years: a prospective study | Q46401033 | ||
| Inadequate treatment with HMG-CoA reductase inhibitors by health care providers | Q46415775 | ||
| Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group | Q46496998 | ||
| Long-term glycemic control relates to mortality in type II diabetes. | Q50614296 | ||
| Detection and treatment of hypertension in patients with non-insulin-dependent diabetes mellitus: does the 'rule of halves' apply to a diabetic population? | Q50624504 | ||
| Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga | Q51566349 | ||
| Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. | Q51570195 | ||
| Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. | Q51574301 | ||
| Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. | Q51578021 | ||
| Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. | Q52236262 | ||
| Cause-specific mortality in a population-based study of diabetes | Q68059236 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hyperglycemia | Q271993 |
| hypercholesterolemia | Q762713 | ||
| type 2 diabetes | Q3025883 | ||
| hypertension | Q95566669 | ||
| P304 | page(s) | 603-609 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes | |
| P478 | volume | 112 |
| Q36133891 | Assessment of care for type 2 diabetic patients at the primary care clinics of a referral hospital |
| Q37404204 | Brave new worlds: how virtual environments can augment traditional care in the management of diabetes |
| Q45184356 | Cardiac risk factor awareness and management in patients with systemic lupus erythematosus |
| Q42653963 | Challenges in preventing cardiovascular complications in type 2 diabetes in primary care |
| Q28195948 | Compliance with Clinical Practice Guidelines for Type 2 Diabetes in Rural Patients: Treatment Gaps and Opportunities for Improvement |
| Q46853623 | Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen). |
| Q48935862 | Cost of an informatics-based diabetes management program |
| Q37419499 | Cost sharing and the initiation of drug therapy for the chronically ill. |
| Q34607444 | Creating a place for caregivers in personal health: the iHealthSpace copilot program and diabetes care |
| Q35147057 | Current management strategies for coexisting diabetes mellitus and obesity |
| Q34337783 | Developing a quality measure for clinical inertia in diabetes care |
| Q28484110 | Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study |
| Q37233760 | Do diabetes-specialty clinics differ in management approach and outcome? A cross-sectional assessment of ambulatory type 2 diabetes patients in two teaching hospitals in Nigeria |
| Q37257538 | Effect of number and type of antidiabetes medications on adherence and glycemia of ambulatory type 2 diabetes patients in southwestern Nigeria |
| Q74189374 | Effectiveness of diabetes management: is improvement feasible? |
| Q44811925 | Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). |
| Q42165226 | Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence |
| Q22306347 | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee |
| Q22306345 | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association |
| Q22306356 | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association |
| Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q29547236 | Heart disease and stroke statistics--2011 update: a report from the American Heart Association |
| Q29547909 | Heart disease and stroke statistics--2012 update: a report from the American Heart Association |
| Q29547691 | Heart disease and stroke statistics--2014 update: a report from the American Heart Association |
| Q24814760 | Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines |
| Q37253892 | Hypertension in diabetes: a call to action |
| Q57414644 | Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study |
| Q93645968 | JournalScan |
| Q44416936 | Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes |
| Q36741476 | Lessons from implementing a combined workflow-informatics system for diabetes management |
| Q33654318 | Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves |
| Q36979423 | Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality |
| Q34036648 | Multiple uncontrolled conditions and blood pressure medication intensification: an observational study |
| Q47260337 | One size does not fit all: the need for a continuous measure for glycemic control in diabetes |
| Q37010393 | Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary |
| Q52929592 | Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers. |
| Q40591607 | Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes |
| Q34704025 | Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. |
| Q33433176 | Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study |
| Q35115553 | The Case for “Outsourcing” Diabetes Care |
| Q28201491 | The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients |
| Q36587618 | Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies |
| Q36082672 | Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study |
| Q28168410 | Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada |
| Q36471487 | Variation in quality of diabetes care at the levels of patient, physician, and clinic. |
Search more.